{"id":"W3177460853","doi":"10.1016/j.jacc.2021.04.083","title":"Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Boehringer Ingelheim; Sanofi; GlaxoSmithKline; Janssen Pharmaceuticals; AstraZeneca; Bayer; Servier; Pfizer; Eli Lilly and Company","keywords":"Medicine; Aspirin; Hazard ratio; Internal medicine; Coronary artery disease; Kidney disease; Stroke (engine); Cardiology; Heart failure; Diabetes mellitus; Rivaroxaban; Confidence interval; Warfarin; Surgery; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005880287,0.0009434543,0.002310144,0.0002797049,0.0002922974,0.0008622367,0.0003475469,0.0008526475,0.00296586],"category_scores_gemma":[0.001523455,0.0003062118,0.002253791,0.0002613059,0.0002311472,0.000583338,0.0003962825,0.001656359,0.0004244379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003521874,"about_ca_system_score_gemma":0.0005515736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006944868,"about_ca_topic_score_gemma":0.001812741,"domain_scores_codex":[0.9996352,0.0001486351,0.00003323194,0.00006507801,0.00003785592,0.00007987362],"domain_scores_gemma":[0.9996165,0.0001353433,0.00006766949,0.00002661154,0.00001918365,0.000134592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8361671,0.003420672,0.03418318,0.001315207,0.00602,0.0008451336,0.00008970795,0.002332353,0.00638499,0.0004585657,0.004920234,0.1038628],"study_design_scores_gemma":[0.3038344,0.1436006,0.5041938,0.0006202763,0.02301868,0.001669612,0.0003966589,0.008348811,0.002175576,0.002806329,0.009154649,0.0001805778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673361,0.0211777,0.0004085672,0.00253469,0.001103639,0.0001315617,0.0006550617,0.00008169263,0.006570909],"genre_scores_gemma":[0.9905549,0.004670329,0.0003200112,0.001034012,0.001578538,0.00006894088,0.0007027632,0.000008945105,0.001061682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00296586,"threshold_uncertainty_score":0.009921789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01223958816175236,"score_gpt":0.2563547939712405,"score_spread":0.2441152058094881,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}